Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

MLA

David O, Walterhouse, et al. “Reduction of Cyclophosphamide Dose for Patients with Subset 2 Low-Risk Rhabdomyosarcoma Is Associated with an Increased Risk of Recurrence: A Report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.” Cancer, vol. 123, no. 12, Aug. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........2a7dbb3acb44079ed8afe7fff63366c1&authtype=sso&custid=ns315887.

APA

David O, W., Alberto S, P., Jane L, M., John C, B., Andrea, H.-J., David M, P., Timothy P, C., James R, A., William H, M., & Douglas S, H. (2016). Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Cancer, 123(12).

Chicago

David O, Walterhouse, Pappo Alberto S, Meza Jane L, Breneman John C, Hayes-Jordan Andrea, Parham David M, Cripe Timothy P, Anderson James R, Meyer William H, and Hawkins Douglas S. 2016. “Reduction of Cyclophosphamide Dose for Patients with Subset 2 Low-Risk Rhabdomyosarcoma Is Associated with an Increased Risk of Recurrence: A Report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.” Cancer 123 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........2a7dbb3acb44079ed8afe7fff63366c1&authtype=sso&custid=ns315887.